Skip to main content
Top
Published in: Abdominal Radiology 8/2017

01-08-2017

Effect of threshold growth as a major feature on LI-RADS categorization

Authors: Victoria Chernyak, Mariya Kobi, Milana Flusberg, Kate C. Fruitman, Claude B. Sirlin

Published in: Abdominal Radiology | Issue 8/2017

Login to get access

Abstract

Purpose

Liver Imaging Reporting and Data System (LI-RADS) uses major features (arterial phase hyperenhancement [APHE], “washout” [WO], “capsule,” diameter, threshold growth [TG]) to codify probability of hepatocellular carcinoma for each observation. This study assessed the effect of removing TG as a major feature on LI-RADS categorization.

Materials and methods

In this HIPAA-compliant, IRB-approved study, all MR and CT clinical reports containing a standardized LI-RADS v2014 template between 4/15–1/17 were retrospectively reviewed for each LR-3, LR-4, and LR-5 reported observation. Two LI-RADS categories were then assigned: one using all LI-RADS major features and one after removing TG as a major feature. The two categories were compared descriptively.

Results

The study included 265 patients (172 [65%] male, mean age 63 [±10] years) with 489 observations (median diameter 14 mm, IQR 10–20 mm), of which 345 (71%) had APHE, 307 (63%) had WO, 86 (18%) had “capsule,” and 72 (15%) had TG. Of 86 observations with TG, 47 (65%) were new observations ≥10 mm, 14 (19%) had diameter increase ≥50% in ≤6 months, and 11 (15%) had diameter increase ≥100% in >6 months. Using all major features, 214/489 (44%) observations were LR-3, 129/489 (26%) were LR-4, and 146/489 (30%) were LR-5. After removing TG, 237/489 (48%) were LR-3, 119/489 (24%) were LR-4, and 133 (27%) were LR-5. Removing TG caused a category downgrade for 35/489 (7%, 95% CI 5–10) observations, including 13/146 (9%, 95% CI 3–14) LR-5 observations.

Conclusion

9% of LR-5 observations would be downgraded without TG.
Literature
1.
go back to reference Tang A, Valasek MA, Sirlin CB (2015) Update on the liver imaging reporting and data system: what the pathologist needs to know. Adv Anat Pathol 22(5):314–322CrossRefPubMed Tang A, Valasek MA, Sirlin CB (2015) Update on the liver imaging reporting and data system: what the pathologist needs to know. Adv Anat Pathol 22(5):314–322CrossRefPubMed
2.
go back to reference Santillan CS, Tang A, Cruite I, Shah A, Sirlin CB (2014) Understanding LI-RADS: a primer for practical use. Magnet Reson Imaging Clin N Am 22(3):337–352CrossRef Santillan CS, Tang A, Cruite I, Shah A, Sirlin CB (2014) Understanding LI-RADS: a primer for practical use. Magnet Reson Imaging Clin N Am 22(3):337–352CrossRef
4.
go back to reference Shah A, Tang A, Santillan C, Sirlin C (2016) Cirrhotic liver: what’s that nodule? The LI-RADS approach. J Magn Reson Imaging. 43(2):281–294CrossRefPubMed Shah A, Tang A, Santillan C, Sirlin C (2016) Cirrhotic liver: what’s that nodule? The LI-RADS approach. J Magn Reson Imaging. 43(2):281–294CrossRefPubMed
5.
go back to reference Wald C, Russo MW, Heimbach JK, et al. (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266(2):376–382CrossRefPubMed Wald C, Russo MW, Heimbach JK, et al. (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266(2):376–382CrossRefPubMed
6.
8.
go back to reference European Association for the Study of the Liver (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943CrossRef European Association for the Study of the Liver (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943CrossRef
9.
go back to reference Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(2):439–474CrossRefPubMedPubMedCentral Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(2):439–474CrossRefPubMedPubMedCentral
10.
go back to reference Kudo M, Matsui O, Izumi N, et al. (2014) JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer. 3(3–4):458–468CrossRefPubMedPubMedCentral Kudo M, Matsui O, Izumi N, et al. (2014) JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer. 3(3–4):458–468CrossRefPubMedPubMedCentral
11.
go back to reference Lee JM, Park JW, Choi BI (2014) 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Dig Dis. 32(6):764–777CrossRefPubMed Lee JM, Park JW, Choi BI (2014) 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Dig Dis. 32(6):764–777CrossRefPubMed
12.
go back to reference Kim TK, Lee KH, Jang HJ, et al. (2011) Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 259(3):730–738CrossRefPubMed Kim TK, Lee KH, Jang HJ, et al. (2011) Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 259(3):730–738CrossRefPubMed
13.
go back to reference Rimola J, Forner A, Tremosini S, et al. (2012) Non-invasive diagnosis of hepatocellular carcinoma ≤2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 56(6):1317–1323CrossRefPubMed Rimola J, Forner A, Tremosini S, et al. (2012) Non-invasive diagnosis of hepatocellular carcinoma ≤2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 56(6):1317–1323CrossRefPubMed
14.
go back to reference Valls C, Cos M, Figueras J, et al. (2004) Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 182(4):1011–1017CrossRefPubMed Valls C, Cos M, Figueras J, et al. (2004) Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 182(4):1011–1017CrossRefPubMed
15.
go back to reference Laghi A, Iannaccone R, Rossi P, et al. (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226(2):543–549CrossRefPubMed Laghi A, Iannaccone R, Rossi P, et al. (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226(2):543–549CrossRefPubMed
16.
go back to reference Choi JW, Lee JM, Kim SJ, et al. (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 267(3):776–786CrossRefPubMed Choi JW, Lee JM, Kim SJ, et al. (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 267(3):776–786CrossRefPubMed
17.
go back to reference Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47(3–5):271–276CrossRefPubMed Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47(3–5):271–276CrossRefPubMed
18.
go back to reference Matsui O, Kobayashi S, Sanada J, et al. (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36(3):264–272CrossRefPubMedPubMedCentral Matsui O, Kobayashi S, Sanada J, et al. (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36(3):264–272CrossRefPubMedPubMedCentral
19.
go back to reference Ishigami K, Yoshimitsu K, Nishihara Y, et al. (2009) Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 250(2):435–443CrossRefPubMed Ishigami K, Yoshimitsu K, Nishihara Y, et al. (2009) Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 250(2):435–443CrossRefPubMed
20.
go back to reference Khan AS, Hussain HK, Johnson TD, et al. (2010) Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging 32(2):360–366CrossRefPubMed Khan AS, Hussain HK, Johnson TD, et al. (2010) Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging 32(2):360–366CrossRefPubMed
21.
go back to reference Forner A, Vilana R, Ayuso C, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47(1):97–104CrossRefPubMed Forner A, Vilana R, Ayuso C, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47(1):97–104CrossRefPubMed
22.
go back to reference Ohkawa K, Imanaka K, Sakakibara M, et al. (2014) Factors related to shift from hepatic borderline lesion to overt HCC diagnosed by CT. Hepato Gastroenterol 61(134):1680–1687 Ohkawa K, Imanaka K, Sakakibara M, et al. (2014) Factors related to shift from hepatic borderline lesion to overt HCC diagnosed by CT. Hepato Gastroenterol 61(134):1680–1687
23.
go back to reference Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42(1):27–34CrossRefPubMed Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42(1):27–34CrossRefPubMed
24.
go back to reference Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61(3):1056–1065CrossRefPubMed Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61(3):1056–1065CrossRefPubMed
25.
go back to reference Burke LM, Sofue K, Alagiyawanna M, et al. (2016) Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol (NY) 41(9):1758–1766CrossRef Burke LM, Sofue K, Alagiyawanna M, et al. (2016) Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol (NY) 41(9):1758–1766CrossRef
26.
go back to reference Darnell A, Forner A, Rimola J, et al. (2015) Liver imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology 275(3):698–707CrossRefPubMed Darnell A, Forner A, Rimola J, et al. (2015) Liver imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology 275(3):698–707CrossRefPubMed
27.
go back to reference Choi SH, Byun JH, Kim SY, et al. (2016) Liver imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Investig Radiol 51(8):483–490CrossRef Choi SH, Byun JH, Kim SY, et al. (2016) Liver imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Investig Radiol 51(8):483–490CrossRef
28.
go back to reference Tamada T, Korenaga M, Yamamoto A, Higaki A, Kanki A, Nishina S, et al. (2016) Assessment of clinical and MRI features of de novo hypervascular HCC using gadoxetic acid-enhanced MRI. Hepatol Res Tamada T, Korenaga M, Yamamoto A, Higaki A, Kanki A, Nishina S, et al. (2016) Assessment of clinical and MRI features of de novo hypervascular HCC using gadoxetic acid-enhanced MRI. Hepatol Res
29.
go back to reference Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178(6):1327–1334CrossRefPubMed Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178(6):1327–1334CrossRefPubMed
30.
go back to reference Sadek AG, Mitchell DG, Siegelman ES, et al. (1995) Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 195(3):753–756CrossRefPubMed Sadek AG, Mitchell DG, Siegelman ES, et al. (1995) Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 195(3):753–756CrossRefPubMed
31.
go back to reference Nakajima T, Moriguchi M, Mitsumoto Y, et al. (2002) Simple tumor profile chart based on cell kinetic parameters and histologic grade is useful for estimating the natural growth rate of hepatocellular carcinoma. Hum Pathol 33(1):92–99CrossRefPubMed Nakajima T, Moriguchi M, Mitsumoto Y, et al. (2002) Simple tumor profile chart based on cell kinetic parameters and histologic grade is useful for estimating the natural growth rate of hepatocellular carcinoma. Hum Pathol 33(1):92–99CrossRefPubMed
32.
go back to reference Kojiro M (2010) Pathological diagnosis at early stage: reaching international consensus. Oncology. 78(Suppl 1):31–35CrossRefPubMed Kojiro M (2010) Pathological diagnosis at early stage: reaching international consensus. Oncology. 78(Suppl 1):31–35CrossRefPubMed
33.
go back to reference Silva MA, Hegab B, Hyde C, et al. (2008) Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 57(11):1592–1596CrossRefPubMed Silva MA, Hegab B, Hyde C, et al. (2008) Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 57(11):1592–1596CrossRefPubMed
34.
go back to reference Sofue K, Sirlin CB, Allen BC, et al. (2016) How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma. J Magn Reson Imaging 43(6):1337–1345CrossRefPubMed Sofue K, Sirlin CB, Allen BC, et al. (2016) How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma. J Magn Reson Imaging 43(6):1337–1345CrossRefPubMed
35.
go back to reference Davenport MS, Khalatbari S, Liu PS, et al. (2014) Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology 272(1):132–142CrossRefPubMedPubMedCentral Davenport MS, Khalatbari S, Liu PS, et al. (2014) Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology 272(1):132–142CrossRefPubMedPubMedCentral
36.
go back to reference Bashir MR, Huang R, Mayes N, et al. (2015) Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging 42(2):305–314CrossRefPubMed Bashir MR, Huang R, Mayes N, et al. (2015) Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging 42(2):305–314CrossRefPubMed
37.
go back to reference Corwin MT, Fananapazir G, Jin M, Lamba R, Bashir MR (2016) Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT. AJR Am J Roentgenol 206(2):307–312CrossRefPubMed Corwin MT, Fananapazir G, Jin M, Lamba R, Bashir MR (2016) Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT. AJR Am J Roentgenol 206(2):307–312CrossRefPubMed
38.
go back to reference Zhang YD, Zhu FP, Xu X, et al. (2016) Liver imaging reporting and data system: substantial discordance between CT and MR for imaging classification of hepatic nodules. Acad Radiol 23(3):344–352CrossRefPubMed Zhang YD, Zhu FP, Xu X, et al. (2016) Liver imaging reporting and data system: substantial discordance between CT and MR for imaging classification of hepatic nodules. Acad Radiol 23(3):344–352CrossRefPubMed
Metadata
Title
Effect of threshold growth as a major feature on LI-RADS categorization
Authors
Victoria Chernyak
Mariya Kobi
Milana Flusberg
Kate C. Fruitman
Claude B. Sirlin
Publication date
01-08-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1105-8

Other articles of this Issue 8/2017

Abdominal Radiology 8/2017 Go to the issue

Classics in Abdominal Imaging

The “polka-dot” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.